Knowledge Distillery

Many pregnant persons in the United States are receiving messenger RNA (mRNA) COVID-19 vaccines, but data are limited on their safety in pregnancy.

Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the…

The mainstay of control of the COVID-19 pandemic is vaccination against SARS-CoV-2.

In this article the authors report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving…

Whether or not persons who have already been infected SARS-CoV-2 should be vaccinated is unclear.

Interim results from a phase 3 trial of the Moderna mRNA-1273 SARS-CoV-2 vaccine indicated 94% efficacy in preventing COVID-19.

Since the start of the vaccination campaign, the development of COVID-19 has been reported in persons who have received one or both doses of mRNA-1273…

• General interest

  •  

     

     

     

     

     

     

     

     

     

     

     

• Academic/Scientific

  •  

     

     

     

     

     

     

     

     

     

     

    …

CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a baculovirus expression system being developed against SARS-CoV-2.

In this phase 1, double-blind, placebo-controlled, block-randomised trial the authors aimed to assess the safety and immunogenicity of an…

The COVID-19 pandemic is having profound mental health consequences for many people.

The comparative performance of different clinical sampling methods for diagnosis of SARS-CoV-2 infection by RT-PCR among populations with suspected…